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CASE REPORT
Vitamin B12 deficiency neuropathy; a 
rare diagnosis in young adults: a case report
Cyril Jabea Ekabe1,5, Jules Kehbila1,2,5, Martin Hongieh Abanda1,3, Benjamin Momo Kadia1,4, 
Carlson‑Babila Sama5,6* and Gottlieb Lobe Monekosso7
Abstract 
Background: Vitamin B12 deficiency is a metabolic disorder with many causes. It often presents with megaloblastic 
anaemia and neurological disorders which entail prompt treatment. The diagnosis of Vitamin B12 deficiency is chal‑
lenging in resource limited‑settings due to limited access to diagnostic tools and unfamiliarity with the disease, owing 
to its rarity especially in young people.
Case presentation: A 28 year old female Cameroonian presented with progressive burning painful sensations on 
the upper trunk, paraesthesia and numbness of the upper and lower limbs for a period of 5 years. Before presenting 
to us, she had consulted in numerous health institutions for which she had been treated for diverse pathologies with 
no relieve of symptoms. After clinical and laboratory evaluation, a diagnosis of vitamin B12 deficiency‑associated 
neuropathy was made. She was placed on oral vitamin B12 supplements at 2 mg daily for 3 months. Follow up was 
marked by good clinical recovery after 1 month of therapy.
Conclusion: Vitamin B12 deficiency neuropathy is a rare debilitating disease that affects mostly the elderly. However; 
young adults with neuropathic symptoms warrant a high index of suspicion. Peripheral blood smears and complete 
blood counts are sufficiently diagnostic in resource‑limited settings.
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Background
Vitamin B12 (VB12) is an essential water soluble vitamin 
important in cellular metabolism and maintenance of the 
integrity of the nervous system [1]. It is important in the 
synthesis of DNA and thus cell division [2]. Deficiency 
in vitamin B12 is associated with impaired erythropoie-
sis and nervous system demyelination, which account 
for most of its clinical manifestations [3, 4]. Globally, the 
most common aetiology of vitamin B12 deficiency is lack 
of intrinsic factor in patients with pernicious anaemia; 
a common finding in the elderly [4]. Other aetiologies 
include dietary deficiency and mal-absorption [5].
Clinically, VB12 deficiency presents mainly with neu-
rological and psychiatric manifestations [5]. Neurological 
impairment usually presents as paraesthesia, numbness 
and ataxia [5, 6]. Laboratory investigations play an impor-
tant role in the diagnosis and determination of the aeti-
ologies of this deficiency. Laboratory investigations vital 
in diagnosing VB12 deficiency include mean corpuscular 
volume (MCV), peripheral blood smear (ovalomacrocy-
tosis and hypersegmented neutrophils), cyanocobalamin 
levels, serum methylmalonic acid and homocysteine [7]. 
Therapeutic trials have also been used for the diagnosis 
of VB12 deficiency [7]. Early diagnosis of VB12 deficiency 
is pivotal for timely management and in preventing long 
term complications which could account for significant 
morbidity. We herein report a rare case of VB 12 defi-
ciency in a young patient from a resource-poor setting.
Case presentation
A 28 year-old sub-Saharan female presented with insidi-
ous onset of painful burning sensations on the upper 
trunk, symmetrical numbness and tingling sensation 
on the hands and feet, progressing over a 5 year-period. 
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These symptoms began as intermittent burning sensa-
tions on the scapulae and pectoral regions of the upper 
trunk, which progressed to numbness and paraesthesia 
of the upper and lower limbs respectively. These were 
associated with mild weakness of the hands and feet, 
insomnia, irritability and constipation. There were no 
urinary symptoms, paralysis, gait disturbances, tremors, 
jaundice, limb swelling, changes in skin colour, or delu-
sion. She had no known history of Human Immunode-
ficiency Virus (HIV) infection, diabetes, thyroid disease, 
syphilis, liver disease, renal disease, diphtheria, spinal 
cord injury or exposure to heavy metals. She is a labora-
tory technician and unmarried. She had been on ome-
prazole for 4  years for recurrent dyspepsia. She neither 
smokes cigarette nor consumes alcohol. She consumes 
meat regularly on weekly bases. A review of her previous 
consultations and laboratory results showed the follow-
ing results; Aspartate amino transferase: 15 U/I, Alanine 
amino transferase: 22  U/I, Haemoglobin: 11  g/dl, HIV 
test: negative, fasting blood sugar: 97  g/dl. Spinal x-ray 
done 1  month prior to consultation was unremarkable. 
She had taken multivitamins, calcium and magnesium 
tablets, tramadol, prednisolone, and benzathin penicil-
lin since the onset of illness. Despite these medications, 
there was no relieve in her symptoms.
On physical examination, her vital signs were stable. 
Her Conjunctivae were mildly pale, sclerae anicteric, and 
tonsils were normal. There were no skin changes, cer-
vical adenopathy, or thyroid mass. Cardio-respiratory 
exam was normal. There was no hepato-splenomegaly 
or signs of liver disease. On examination of the neuro-
logical system, pupillary size and reflexes were normal. 
Cranial nerves were normal. Muscle tone and power 
were normal on both upper and lower limbs. Sensation 
to touch, pain and temperature were normal. There was 
impaired proprioception in both upper limbs. Tendon 
and cutaneous reflexes were normal. Lhermitte’s sign 
was absent. Based on her presentation we suspected a 
peripheral neuropathy with HIV peripheral neuropathy, 
neurosyphilis, and vitamin B12 deficiency as differentials. 
Blood tests showed Hemoglobin: 10.5  g/dl, Red blood 
cell count: 3 million/mcl, reticulocyte count: 0.3%, Mean 
Corpuscular Volume (MCV):110 fl, WBC: 8500 cells/μl, 
HIV test: negative, Treponema pallidum hematoglutinin 
assay (TPHA): negative, erythrocyte sedimentation rate 
(ESR): 10  mm/h, and peripheral blood smear analysis: 
ovalo-macrocytosis, and hyper-segmented neutophils. 
Stool exam and urinalysis were normal (Table 1). Serum 
cyanocobalamin levels were not assessed because of lack 
of diagnostic tools. A diagnosis of vitamin B12 deficiency 
related peripheral neuropathy was made based on her 
symptoms, ovalo-macrocytosis and hyper-segmented 
neutrophils on peripheral blood smear. She was treated 
with oral vitamin B12 tablets, at doses of 2 mg daily for 
3 months. 1 month of therapy was marked with improve-
ment in neurological symptoms and a follow up MCV of 
97 fl, red blood cell count of 4.1 million/µl, and reticulo-
cyte count of 0.95%.
Discussion and conclusion
Vitamin B12 is an essential water soluble vitamin which 
is important in cellular metabolism and maintenance of 
the integrity of the nervous system [1]. VB12 deficiency 
has numerous aetiologies which include; lack of intrinsic 
factor, nutritional deficiency, malabsorption and compe-
tition for VB12 [1, 4, 5].
The main neurological symptoms include: paraesthe-
sia [8–12], ataxia [9–12], and limb weakness [9, 11]. The 
most prevalent psychiatric symptoms associated with 
B12 deficiency include, delusions [12, 13], irritability [13, 
14], and decreased interest [15, 16]. Other manifestations 
included depression [12, 16] and sleep disturbances [12, 
16]. These neurological symptoms are associated with 
other common illnesses like HIV infection, diabetes, 
syphilis, alcoholism, and some medications, thus posing 
a diagnostic challenge [17].
Basic laboratory investigations like full blood count 
(FBC) and peripheral blood smear analysis are vital in the 
diagnosis of this pathology [7] as evidenced by our case. 
Ovalo-macrocytosis and hyper-segmented neutrophils 
are important findings in VB12 deficiency [18], especially 
in settings were serum cyanocobalamin, methylmalonic 
and homocystein levels cannot be assessed. However, 
studies have designated that serum levels of VB12 can 
be unreliable for the assessment of VB12 deficiency [19]. 
Serum Transcobalamin II and methylmalonic acid levels 
are at present considered the most specific laboratory 
indices [19]. Nonetheless, Hyper-segmented neutrophils 
is reported to have a sensitivity of 98% [20], compared 
to serum cyanocobalamin with a sensitivity of 90–95% 
[21]. Thus, making peripheral blood smear analysis a cost 
effective tool in the diagnosis of VB12 deficiency, espe-
cially in settings like ours.
Anti-intrinsic factor and anti-parietal cell antibodies 
are important in diagnosing pernicious anaemia; a major 
aetiology of VB12 deficiency [7]. Conversely, mal-absorp-
tion from probable pernicious anaemia or chronic ome-
prazole use was the most likely aetiologies considered in 
this case. The response to oral VB12 supplement there-
fore pointed to chronic omeprazole use because intrinsic 
factor is needed for oral absorption.
The various methods of VB12 replacement therapy 
includes parenteral and oral [1]. Our patient was man-
aged with oral VB12 tablets due to unavailability of the 
parenteral forms. It is known that VB12 is absorbed 
actively through its association with intrinsic factor. 
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However, 1–2% of VB12 absorption occurs passively [22], 
thus oral replacement therapy can be as effective as par-
enteral therapy provided they are administered at high 
doses (2 mg daily) [23].
Therapeutic trials have also played vital roles in con-
firming VB12 deficiency, especially with follow up 
increases in MCV, RBC and Reticulocyte count [7, 24]. 
Follow up analysis of our case showed normalization of 
MCV, RBC and reticulocyte counts, which are important 
indices to assess therapeutic diagnosis and response in 
patients with VB12 deficiency.
This case emphasizes the importance of increased 
index of suspicion of Vitamin B12 deficiency in patients 
presenting with peripheral neuropathic symptoms. It also 
underscores the invaluable role of basic investigations 
like peripheral blood smear and the vitality of therapeutic 
trials which are pivotal to the timely detection and man-
agement of vitamin B12 associated neurological disease 
in resource-limited settings. Although this pathology is 
common in the old, young patients should be considered.
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